AU4338589A - A preparation of plasminogen activator expressed in prokaryotes - Google Patents

A preparation of plasminogen activator expressed in prokaryotes

Info

Publication number
AU4338589A
AU4338589A AU43385/89A AU4338589A AU4338589A AU 4338589 A AU4338589 A AU 4338589A AU 43385/89 A AU43385/89 A AU 43385/89A AU 4338589 A AU4338589 A AU 4338589A AU 4338589 A AU4338589 A AU 4338589A
Authority
AU
Australia
Prior art keywords
prokaryotes
preparation
plasminogen activator
activator expressed
expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43385/89A
Other versions
AU620927B2 (en
Inventor
Stephan Fischer
Ulrich Kohnert
Ulrich Opitz
Rainer Rudolph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU4338589A publication Critical patent/AU4338589A/en
Application granted granted Critical
Publication of AU620927B2 publication Critical patent/AU620927B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AU43385/89A 1988-09-28 1989-09-28 A preparation of plasminogen activator expressed in prokaryotes Ceased AU620927B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3832898A DE3832898A1 (en) 1988-09-28 1988-09-28 PRAEPARATE OF EXPRESSED PLASMINOGEN ACTIVATOR IN PROKARYONS
DE3832898 1988-09-28

Publications (2)

Publication Number Publication Date
AU4338589A true AU4338589A (en) 1990-04-18
AU620927B2 AU620927B2 (en) 1992-02-27

Family

ID=6363884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43385/89A Ceased AU620927B2 (en) 1988-09-28 1989-09-28 A preparation of plasminogen activator expressed in prokaryotes

Country Status (7)

Country Link
EP (1) EP0361475A1 (en)
JP (1) JPH02503635A (en)
AU (1) AU620927B2 (en)
DE (1) DE3832898A1 (en)
DK (1) DK130390D0 (en)
IL (1) IL91774A0 (en)
WO (1) WO1990003388A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004382A1 (en) * 1990-09-05 1992-03-19 Bunge (Australia) Pty. Ltd. Solubilization of proteins in active forms

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140699A1 (en) * 1991-01-11 1992-07-16 Boehringer Mannheim Gmbh RECOMBINANT IGA PROTEASE
US5965424A (en) * 1991-01-11 1999-10-12 Boehringer Mannheim Gmbh Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
JP3288720B2 (en) * 1996-06-11 2002-06-04 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for activating denatured protein
US20090130714A1 (en) * 2007-09-24 2009-05-21 Reliance Life Sciences Pvt.Ltd. Process for purifying recombinanat tissue plasminogen activator (TPA)
CN103852527B (en) * 2012-12-05 2015-05-13 中国科学院大连化学物理研究所 High-flux protein sample pre-treatment device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (en) * 1982-12-22 1984-10-02 Genentech Inc
JPS6229975A (en) * 1985-08-01 1987-02-07 Mitsui Toatsu Chem Inc Purification of crude tpa
JPH0672105B2 (en) * 1985-10-02 1994-09-14 持田製薬株式会社 Thrombolytic agent and manufacturing method thereof
DE3537708A1 (en) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh METHOD FOR ACTIVATING T-PA AFTER EXPRESSION IN PROKARYONTS
FR2594845B1 (en) * 1986-02-21 1989-12-01 Genetica MICROBIOLOGICAL PREPARATION OF THE HUMAN PLASMINOGEN TISSUE ACTIVATOR (T-PA) AND CONVERSION OF THE ENZYME SO OBTAINED IN ITS ACTIVE FORM
DE3611817A1 (en) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh METHOD FOR RENATURING PROTEINS
DE3613401A1 (en) * 1986-04-21 1987-12-17 Boehringer Mannheim Gmbh METHOD FOR PRODUCING PLASMINOGEN ACTIVATORS IN PROKARYONTS
DE3643158A1 (en) * 1986-04-21 1987-11-19 Boehringer Mannheim Gmbh TISSUE PLASMINOGEN ACTIVATOR (TPA) DERIVATIVE AND ITS PRODUCTION
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
JPH0779692B2 (en) * 1986-05-07 1995-08-30 三井東圧化学株式会社 Method for separating single-stranded t-PA and double-stranded t-PA
JPH01500563A (en) * 1986-07-16 1989-03-01 セルテック　リミテッド Purification method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004382A1 (en) * 1990-09-05 1992-03-19 Bunge (Australia) Pty. Ltd. Solubilization of proteins in active forms

Also Published As

Publication number Publication date
DK130390A (en) 1990-05-25
DK130390D0 (en) 1990-05-25
WO1990003388A1 (en) 1990-04-05
EP0361475A1 (en) 1990-04-04
AU620927B2 (en) 1992-02-27
JPH02503635A (en) 1990-11-01
DE3832898A1 (en) 1990-04-12
IL91774A0 (en) 1990-06-10

Similar Documents

Publication Publication Date Title
AU3344889A (en) Improvements in and relating to packaging
AU4378989A (en) Combined edm and ultrasonic drilling
AU3003389A (en) Customizable circuitry
AU6110286A (en) Poly-kringle plasminogen activator
AU5330286A (en) Modified tissue-type plasminogen activator
AU6806487A (en) Tissue plasminogen activator
AU4338589A (en) A preparation of plasminogen activator expressed in prokaryotes
AU613543B2 (en) Preparation of halofluorobenzenes
AU3502789A (en) Composition and use
AU4539389A (en) Improvements in and/or relating to crib walls
AU6180486A (en) Novel tissue plasminogen activator derivatives
AU4403289A (en) Targetting agents
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU3838189A (en) Tissue plasminogen activator analogues having improved activity
AU4060289A (en) Therapeutic agents
AU4494289A (en) Improvements in and relating to catheters
AU3187489A (en) Therapeutic agents
AU3723589A (en) Therapeutic composition
AU3008289A (en) Novel thiorhodamines and a novel method of preparation
AU4093789A (en) Transermal therapeutic composition
AU4496089A (en) Aryloxyaldehydes and their manufacture
AU7090787A (en) Tissue plasminogen activator
AU4297789A (en) Variable-width molding and brightwork
AU4862790A (en) New tissue plasminogen activator
AU4000489A (en) Phenylalkylthiophenes and related compounds